Patent Issued to Inhalation, Inc. on Methods to Prevent, Treat, and Cure Colds, Influenzas, Tuberculosis, and Other Respiratory Infections

WOODINVILLE, Wash.--(BUSINESS WIRE)--Inhalation, Inc. was issued the U.

S. Patent today entitled Methods and Apparatus to Prevent Colds, Influenzas, Tuberculosis and which is U.S.

Patent No. 7,150,888. essential oils to prevent, treat and cure colds and influenzas.

These these oils as possessing significant antibacterial, antiviral, and The patent also describes inhaling such vapors to prevent, treat, and cure infections of Mycobacterium tuberculosis that causes TB. W. Banning Vail, Ph.

D., a MIT-trained physicist and holder of over 65 patents worldwide, and Marilyn L. Vail, president of Inhalation, Inc.

, The company was previously granted U.S. Patent No.

6,447,816 entitled Methods and Apparatus to Prevent Colds, Flus, and Infections of the Human September 10, 2002. The company was also previously granted U.S.

Patent No. 7,048,953 entitled Methods and Apparatus to Prevent, Treat, and Cure Infections of the Human Respiratory System that was issued on May 23, 2006. Other U.

S. patent applications filed by and Apparatus to Prevent, Treat, and Cure Infections of the Human Tularemia, Hemorrhagic Fever Viruses, Tuberculosis and Other Inhaled and Apparatus to Prevent Treat, and Cure the Symptoms of Nausea Caused (that was Published on July 21, 2005 as US 2005/0158411 A1). inhaling such vapors to prevent, treat, and cure infections of avian Inhalation, Inc.

, based in Woodinville, WA, was founded in 2000 to oils to prevent, treat, and cure a wide range of human respiratory diseases. These inhaled substances have an immediate and direct impact on the entire respiratory system, which is in contrast to ingested medications and typical vaccines. The company provides other inhalers headaches, stress, insomnia, nausea, and women s health issues.